Cargando…
EGFR-TKIs与化疗比较一线治疗非小细胞肺癌疗效的meta分析
BACKGROUND AND OBJECTIVE: Epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) has been used for the first-line treatment of non-small cell lung cancer (NSCLC) and has shown good clinical effects. However, some patients fail to benefit from this treatment. The aim of this study is t...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000008/ https://www.ncbi.nlm.nih.gov/pubmed/25800570 http://dx.doi.org/10.3779/j.issn.1009-3419.2015.03.04 |